Biotech Stocks catch a Second Wind Helped by Tech Stocks…Update-4
ALERT 3/21/19...BIOGEN (BIIB) down 28% to $233 after dropping Alzheimer's Disease late stage trial; another failed clinical stage drug in AD. (more later). IBB down 2.5%. ====== 3/20/19...a whipsaw day...Powell comes to market rescue with "economy is growing at a solid pace" and leaving rates...
Sideways Market Vexes Traders: Biotech Stocks are Fading…Updates-3 Rally Time!
Update-3...3/11...Gene Therapy stocks go green screen! Big 5% winners: VYGR NTLA BLUE EDIT See complete list below (paste list into yahoo finance for tracking) Update-2...3/11...Market gets support from 60 Minutes-Powell comments and Gene Therapy; NASDAQ up 1.77%; XBI up 1.74% to $87.94 as of...
Biotech Sell-Off: Momentum Eases on Profit Taking and Geopolitical Uncertainty…Update-2 Gene Therapy
Update-2...Biotech rally Friday and Gene Therapy stocks One clue to the stealth rally on Friday is this article in Barron's published Saturday (? hmmm) Why Big Pharma is Diving into Gene Therapy If you cannot access this article and are not a subscriber go plunk down $5 as there is other good...
Small Cap Biotechs Lead the Market in 2019 Up 20% YTD…GNMK, ONCE, XBI-Updates
Update: 1:40 EST 2/25... Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%. Another big deal as GE sells healthcare business to Danher (DHR) for $21.4B; GE up 8.26%, DHR up 8.38%. ========== M&A Drives Mid and Small Cap Biotechs Stocks Higher The Small Cap...
J.P.Morgan Healthcare Conference: Picks and Trades… Updates GNMK
Update: GenMark (GNMK) Soars on Q4 and Full Year 2018 Results Revenues of $70.8M were 35% over 2017 Results Q4 Revenues were $19.4M an increase of 21% over prior year. ePlex Revenues for Q4 were 412.1M an increase of 110% over prior year. Loss per share was reduced from 26c per share to 21c per...